Living Pharmaceutical Lives (eBook, PDF)
Redaktion: Ballantyne, Peri; Ryan, Kath
40,95 €
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
40,95 €
Als Download kaufen
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
20 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
40,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
20 °P sammeln
Living Pharmaceutical Lives (eBook, PDF)
Redaktion: Ballantyne, Peri; Ryan, Kath
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Increasingly, pharmaceuticals are available as the solutions to a wide range of human health problems and health risks, minor and major. This book portrays how pharmaceutical use is, at once, a solution to, and a difficulty for, everyday life.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
Andere Kunden interessierten sich auch für
- Living Pharmaceutical Lives (eBook, ePUB)40,95 €
- Rebecca Hayley VenablesA Practical Guide to Medicine Administration (eBook, PDF)33,95 €
- Wendy JonesBreastfeeding and Medication (eBook, PDF)42,95 €
- Shibley RahmanLiving with Frailty (eBook, PDF)42,95 €
- Sex, Intimacy and Living with Life-Shortening Conditions (eBook, PDF)40,95 €
- William N. KellyPharmacy (eBook, PDF)70,95 €
- Ethan B RussoCannabis Therapeutics in HIV/AIDS (eBook, PDF)49,95 €
-
-
-
Increasingly, pharmaceuticals are available as the solutions to a wide range of human health problems and health risks, minor and major. This book portrays how pharmaceutical use is, at once, a solution to, and a difficulty for, everyday life.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 232
- Erscheinungstermin: 12. Mai 2021
- Englisch
- ISBN-13: 9781000383973
- Artikelnr.: 61307820
- Verlag: Taylor & Francis
- Seitenzahl: 232
- Erscheinungstermin: 12. Mai 2021
- Englisch
- ISBN-13: 9781000383973
- Artikelnr.: 61307820
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Peri Ballantyne is Professor of the Department of Sociology, Trent University, Peterborough, Ontario, and adjunct Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada. A health sociologist, Peri has focused her research on employment and work as social determinants of health, and on pharmaceutical use across the life course. In her research, Peri seeks to make explicit the ways in which pharmaceuticals are subject to social, political and economic forces that influence who accesses them and to what outcome. Kath Ryan is Professor Emerita of the School of Pharmacy, University of Reading. She is an academic pharmacist and experienced qualitative researcher who has devoted her career, along with international colleagues, to the development of Social Pharmacy as a discipline for improved understanding of the use of medicines.
1.Introduction: Living pharmaceutical lives 2.Drugs at work: implicated in
the making of the neoliberal worker 3.Medicine-use narratives on the
margins: managing Type-2 diabetes without medical insurance 4.Medicine use
for severe asthma: people's perspectives 5.Pregnancy, urinary tract
infections and antibiotics: pre-natal attachment and competing health
priorities 6."What the medications do is that lovely four-lettered word -
hope": a phenomenological investigation of older people's lived experiences
of medication use following cancer diagnosis 7.The paradox of vaccine
hesitancy and refusal: public health and the moral work of motherhood 8.The
pharmaceutical imaginary of heart disease: pleasant futures and problematic
present 9.A Shot in the Dark? Ontario Girls, Informed Consent and HPV
Vaccination 10.Reflections on the use of antiretroviral treatment among
HIV+ men who have sex with men (MSM) in Nigeria 11.Opioid analgesics,
stigma, shame and identity 12.The drama of medicines: narratives of living
with Postural Tachycardia Syndrome 13.The (developing) pharmaceutical
solution(s) to COVID-19: navigating global tensions around the distribution
of therapeutics and vaccines 14.Conclusion: What of Pharmaceutical Lives?
the making of the neoliberal worker 3.Medicine-use narratives on the
margins: managing Type-2 diabetes without medical insurance 4.Medicine use
for severe asthma: people's perspectives 5.Pregnancy, urinary tract
infections and antibiotics: pre-natal attachment and competing health
priorities 6."What the medications do is that lovely four-lettered word -
hope": a phenomenological investigation of older people's lived experiences
of medication use following cancer diagnosis 7.The paradox of vaccine
hesitancy and refusal: public health and the moral work of motherhood 8.The
pharmaceutical imaginary of heart disease: pleasant futures and problematic
present 9.A Shot in the Dark? Ontario Girls, Informed Consent and HPV
Vaccination 10.Reflections on the use of antiretroviral treatment among
HIV+ men who have sex with men (MSM) in Nigeria 11.Opioid analgesics,
stigma, shame and identity 12.The drama of medicines: narratives of living
with Postural Tachycardia Syndrome 13.The (developing) pharmaceutical
solution(s) to COVID-19: navigating global tensions around the distribution
of therapeutics and vaccines 14.Conclusion: What of Pharmaceutical Lives?
1.Introduction: Living pharmaceutical lives 2.Drugs at work: implicated in
the making of the neoliberal worker 3.Medicine-use narratives on the
margins: managing Type-2 diabetes without medical insurance 4.Medicine use
for severe asthma: people's perspectives 5.Pregnancy, urinary tract
infections and antibiotics: pre-natal attachment and competing health
priorities 6."What the medications do is that lovely four-lettered word -
hope": a phenomenological investigation of older people's lived experiences
of medication use following cancer diagnosis 7.The paradox of vaccine
hesitancy and refusal: public health and the moral work of motherhood 8.The
pharmaceutical imaginary of heart disease: pleasant futures and problematic
present 9.A Shot in the Dark? Ontario Girls, Informed Consent and HPV
Vaccination 10.Reflections on the use of antiretroviral treatment among
HIV+ men who have sex with men (MSM) in Nigeria 11.Opioid analgesics,
stigma, shame and identity 12.The drama of medicines: narratives of living
with Postural Tachycardia Syndrome 13.The (developing) pharmaceutical
solution(s) to COVID-19: navigating global tensions around the distribution
of therapeutics and vaccines 14.Conclusion: What of Pharmaceutical Lives?
the making of the neoliberal worker 3.Medicine-use narratives on the
margins: managing Type-2 diabetes without medical insurance 4.Medicine use
for severe asthma: people's perspectives 5.Pregnancy, urinary tract
infections and antibiotics: pre-natal attachment and competing health
priorities 6."What the medications do is that lovely four-lettered word -
hope": a phenomenological investigation of older people's lived experiences
of medication use following cancer diagnosis 7.The paradox of vaccine
hesitancy and refusal: public health and the moral work of motherhood 8.The
pharmaceutical imaginary of heart disease: pleasant futures and problematic
present 9.A Shot in the Dark? Ontario Girls, Informed Consent and HPV
Vaccination 10.Reflections on the use of antiretroviral treatment among
HIV+ men who have sex with men (MSM) in Nigeria 11.Opioid analgesics,
stigma, shame and identity 12.The drama of medicines: narratives of living
with Postural Tachycardia Syndrome 13.The (developing) pharmaceutical
solution(s) to COVID-19: navigating global tensions around the distribution
of therapeutics and vaccines 14.Conclusion: What of Pharmaceutical Lives?